Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet’s Disease: Eight Consecutive Cases

The long-term efficacy and safety of adalimumab (ADA) for the treatment of intestinal Behcet’s disease (BD) in the clinical setting have not been evaluated previously. This retrospective study evaluated the 52-week efficacy of ADA in BD patients. A total of eight patients who were refractory to conv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanida, Satoshi, Mizoshita, Tsutomu, Nishie, Hirotada, Ozeki, Keiji, Katano, Takahito, Shimura, Takaya, Kubota, Eiji, Kataoka, Hiromi, Kamiya, Takeshi, Joh, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780498/
https://www.ncbi.nlm.nih.gov/pubmed/26985255
http://dx.doi.org/10.14740/jocmr2477w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780498/
https://www.ncbi.nlm.nih.gov/pubmed/26985255
http://dx.doi.org/10.14740/jocmr2477w

Ejemplares similares